Researchers In Orlando Are Making Strides in Long-Acting HIV Medications
Researchers in Orlando are making strides in long-acting HIV medications. About 20 years ago, an HIV diagnosis was often seen as a death sentence, but progress in medical research has transformed the lives of those living with HIV. At the Orlando Immunology Center, Research Director Dr. Charlotte-Paige Rolle is dedicated to enhancing the quality of life for HIV patients through ongoing clinical trials on long-acting HIV medications.
The latest breakthrough is Cabenuva, an antiretroviral medication used for treating HIV and AIDS. Cabenuva is comprised of two drugs—one from the integrase class and the other from the non-nuc class—offering long-lasting effects for patients. People like Ida Starks, who has been living with HIV for 23 years, have experienced life-changing benefits from these medications. Dr. Federico Hinestrosa, her physician at the Orlando Immunology Center, manages her Cabenuva injections every other month, keeping her viral load undetectable.
Long-Acting HIV Medications
This groundbreaking treatment is a stark contrast to the past when patients had to endure taking up to 30 pills a day. Dr. Rolle highlights that this is just the beginning, and the medical community is constantly striving to improve patient results. For instance, they are actively exploring long-acting oral drug options, considering that some patients prefer them over injections.
Despite the noteworthy progress made, the ultimate goal remains to find a cure for HIV. Dr. Rolle and her team at the Orlando Immunology Center are optimistic about the future, with promising cure studies presently in progress. These studies involve retraining or re-modulating the immune system to tackle the virus.
Dr. Rolle's dedication to HIV research and long-acting HIV medications stems from the persistent chase for better treatment options and, eventually, a cure. As they continue to innovate and advance their therapies, the hope of eliminating HIV once and for all entirely remains at the forefront of their mission.
The Orlando researchers' commitment to improving the lives of those with HIV echoes their steadfast determination to achieve a future free from the burden of this virus. As they pave the way for state-of-the-art therapies, there is sincere optimism that the best is yet to come for HIV patients, inching ever closer to the goal of a cure.